- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02230826
Observational Study to Evaluate Long-Term Outcome in Hip Arthroplasty
March 14, 2023 updated by: Corin
Multicentric Observational PMCF Study to Evaluate Long-term Outcome, Performance and Safety of Implantable Devices in Hip Arthroplasty
This long-term outcomes study is designed to collect safety and efficacy data on designated, commercially available, hip arthroplasty products.
Study Overview
Status
Recruiting
Detailed Description
Outcome data collected from this study will be used for Post Market Surveillance (PMS) and Clinical Evaluations on Corin hip devices and will support peer-reviewed publications on products performance and safety at long term follow-up.
Study Type
Observational
Enrollment (Anticipated)
2500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Vanessa Grimaud
- Email: vanessa.grimaud@coringroup.com
Study Locations
-
-
-
Bordeaux, France, 33000
- Active, not recruiting
- CHU de Bordeaux - Groupe hospitalier Pellegrin
-
Cannes, France, 06400
- Recruiting
- clinique Oxford Cannes
-
Contact:
- Mathieu NICOLAS, MD
-
Principal Investigator:
- Mathieu NICOLAS, MD
-
Dunkerque, France, 59385
- Not yet recruiting
- Ch Dunkerque
-
Contact:
- Nicolas JAN, MD
-
Principal Investigator:
- Nicolas JAN, MD
-
Hénin-Beaumont, France, 62254
- Recruiting
- Polyclinique Henin Beaumont
-
Contact:
- Pierre CHOLEWINSKI, MD
-
Contact:
- Romain GALMICHE, MD
-
Principal Investigator:
- Pierre CHOLEWINSKI, MD
-
Principal Investigator:
- Romain GALMICHE, MD
-
Nice, France, 06000
- Recruiting
- Chu de Nice
-
Contact:
- Régis BERNARD DE DOMPSURE, MD
-
Principal Investigator:
- Régis BERNARD DE DOMPSURE, MD
-
Principal Investigator:
- Jean-François GONZALEZ, MD,PhD
-
Orléans, France, 45000
- Active, not recruiting
- Centre Hospitalier Régionnal d'Orléans - Site La Source
-
Paris, France, 75014
- Recruiting
- Clinique Arago
-
Contact:
- Dorick PASSERON, MD
-
Principal Investigator:
- Dorick PASSERON, MD
-
Paris, France, 75020
- Recruiting
- Hôpital de la Croix Saint-Simon
-
Contact:
- Antoine MOUTON, MD
-
Principal Investigator:
- Antoine MOUTON, MD
-
Principal Investigator:
- Luc LHOTELLIER, MD
-
Pessac, France, 33600
- Active, not recruiting
- Hôpital Privé Saint-Martin
-
Roubaix, France, 59100
- Not yet recruiting
- Hôpital Provo
-
Contact:
- François GIRAUD, MD
-
Principal Investigator:
- François GIRAUD, MD
-
St Georges de Didonne, France, 17110
- Recruiting
- Polyclinique St Georges de Didonne
-
Contact:
- Christine LAUTRIDOU, MD
-
Principal Investigator:
- Christine LAUTRIDOU, MD
-
Toulouse, France, 31000
- Terminated
- Médipôle Garonne
-
Valenciennes, France, 59300
- Recruiting
- Hopital Jean Bernard
-
Contact:
- Charles BERTON, MD
-
Principal Investigator:
- Charles BERTON, MD
-
Sub-Investigator:
- Alexandre BLAIRON, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Cohort of patients with a partial or total hip replacement (Corin implants)
Description
Inclusion Criteria:
- Man or woman >18 years
- Subjects with indication of arthroplasty surgery with Corin hip devices which are under assessment as part of this PMCF study
- Subjects who agreed for study participation.
Exclusion Criteria:
- Subjects with existing tumour and/or particularly high surgical risk-
- Subjects with anaesthetic risk class IV or higher
- Subjects under guardianship and/or unable to follow procedures or matters related to the study (examples: Illiterate, recent psychotic or mania disorders and / or inability to comply with usual follow-up visits.)
- Contraindications for arthroplasty with a Corin hip devices as per product IFU
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
---|
Patients with Hip arthroplasty
Patients with Hip implants.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluation of long-term outcome after hip arthroplasty with Corin implants.
Time Frame: At 10 years
|
Implants revision rate at 10-year FU hip arthroplasty
|
At 10 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluation of long-term outcome after hip arthroplasty with Corin implants at 15 and 20-year FU.
Time Frame: at 15- and 20-year
|
Implants revision rate at 15- and 20-year FU.
|
at 15- and 20-year
|
Evaluation of clinical performance of Corin hip implants
Time Frame: starting intraoperatively up to 20-year FU
|
Change of Patient Reported Outcome Measures (PROMs)
|
starting intraoperatively up to 20-year FU
|
Evaluation of Safety of Corin hip implants
Time Frame: starting intraoperatively up to 20-year FU
|
Number, severity and causal relationship of procedure or implant-related Adverse Events
|
starting intraoperatively up to 20-year FU
|
Radiological evaluation of positioning and osteointegration of Corin hip implants.
Time Frame: starting intraoperatively up to 20-year FU
|
Number, thickness and location of radiolucent lines, osteolysis and heterotopic ossifications reported via radiological evaluation
|
starting intraoperatively up to 20-year FU
|
Evaluation of patient quality of life
Time Frame: starting intraoperatively up to 20-year FU
|
Improvement of quality of life via EQ-5D-5L scores.
|
starting intraoperatively up to 20-year FU
|
Evaluation of patient satisfaction following surgery
Time Frame: 3 months ; 2.5-year; 6, 11, 15, 20-year visits
|
Improvement of patient's satisfaction
|
3 months ; 2.5-year; 6, 11, 15, 20-year visits
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Goulven Rochcongar, MD, University Hospital, Caen
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2014
Primary Completion (Anticipated)
December 1, 2034
Study Completion (Anticipated)
December 1, 2044
Study Registration Dates
First Submitted
August 29, 2014
First Submitted That Met QC Criteria
September 2, 2014
First Posted (Estimate)
September 3, 2014
Study Record Updates
Last Update Posted (Actual)
March 15, 2023
Last Update Submitted That Met QC Criteria
March 14, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1302-T-HIPLTO-RM
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Femur Head Necrosis
-
Guangdong Provincial People's HospitalUnknownAvascular Necrosis of Femur Head
-
University Hospital, LilleTerminatedAseptic Necrosis of Femur HeadFrance
-
Banc de Sang i TeixitsEuropean Regional Development Fund; Ministerio de Sanidad, Servicios Sociales... and other collaboratorsCompleted
-
Erasme University HospitalUniversity of Liege; Bone Therapeutics S.ACompletedAvascular Necrosis of Femur HeadBelgium
-
Universidad Autonoma de MadridCompletedAvascular Necrosis of the Femoral HeadItaly, France, Germany, Spain
-
University Hospital, Basel, SwitzerlandWithdrawnAvascular Necrosis of the Femoral Head
-
R-BioSMG-SNU Boramae Medical CenterCompletedAvascular Necrosis of the Femoral HeadKorea, Republic of
-
Global Stem Cell Center, BaghdadRecruitingAvascular Necrosis of the Femoral HeadIraq
-
National Health Research Institutes, TaiwanUnknown
-
Seoul National University Bundang HospitalNovartis Korea Ltd.CompletedAvascular Necrosis of Femoral HeadKorea, Republic of